These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35020045)

  • 1. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
    Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
    JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.
    Wadsworth E; Hines LA; Hammond D
    Subst Abus; 2022; 43(1):943-948. PubMed ID: 35420977
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
    Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020.
    Goodman S; Wadsworth E; Hammond D
    J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016-2019.
    Klein TA; Dilley JA; Graves JM; Liebelt EL
    Clin Toxicol (Phila); 2022 Sep; 60(9):1024-1028. PubMed ID: 35942512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of cannabis use risk to mental health among youth in Canada, England and the United States from 2017 to 2021.
    Lemos MK; Taylor E; Wadsworth E; Reid JL; Hammond D; East K
    Drug Alcohol Depend; 2023 Sep; 250():110904. PubMed ID: 37549543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
    Marquette A; Iraniparast M; Hammond D
    BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
    Rotermann M; Pagé MM
    Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited.
    Wadsworth E; Hammond D
    Drug Alcohol Rev; 2018 Nov; 37(7):903-911. PubMed ID: 29992695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis advertising, promotion and branding: Differences in consumer exposure between 'legal' and 'illegal' markets in Canada and the US.
    Rup J; Goodman S; Hammond D
    Prev Med; 2020 Feb; 133():106013. PubMed ID: 32027914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020.
    Okey SA; Castro SA; Waddell JT; Jones CB; Blake AJ; O'Rourke HP; Davis MC; Meier MH
    Int J Drug Policy; 2022 Feb; 100():103531. PubMed ID: 34818602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 19. Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
    AminiLari M; Busse JW; Turna J; MacKillop J
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1133-1139. PubMed ID: 35333612
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
    Morean ME; Lederman IR
    Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.